Cite
MLA Citation
A Strangfeld et al.. “Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs.” Annals of the rheumatic diseases, vol. 76, no. 3, 2017, pp. 504–510. http://access.bl.uk/ark:/81055/vdc_100130160619.0x00005e